Naloxegol Oxalate | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Naloxegol Oxalate
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Naloxegol Oxalate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

4 API Suppliers, 3 USDMF, 1 EU WC, 5 NDC API, 1 Listed Suppliers, $ API Reference Price

4 API Suppliers
3 USDMF
1 EU WC
5 NDC API
1 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

9 Drugs in Development

9 Drugs in Development

FINISHED DOSAGE FORMULATIONS

17 FDF Dossiers, 4 FDA Orange Book, 11 Europe, 2 Canada

17 FDF Dossiers
4 FDA Orange Book
11 Europe
2 Canada

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 12.5MG BASE, TABLET;ORAL - EQ 25MG BASE

TABLET;ORAL - EQ 12.5MG BASE
TABLET;ORAL - EQ 25MG BASE

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Rochem International Inc, 14 SPI Pharma, 3 DKSH, 3 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 1 Clariant, 10 Corel Pharma Chem, 3 DFE Pharma, 5 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 13 Roquette, 6 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Coating Systems & Additives, 39 Fillers, Diluents & Binders, 19 Direct Compression, 19 Controlled & Modified Release, 18 Disintegrants & Superdisintegrants, 13 Taste Masking, 13 Chewable & Orodispersible Aids, 12 Granulation, 12 Thickeners and Stabilizers, 10 Co-Processed Excipients, 9 Lubricants & Glidants, 8 Film Formers & Plasticizers, 5 Parenteral, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Rheology Modifiers, 2 Solubilizers, 2 Emulsifying Agents, 2 Topical, 1 Surfactant & Foaming Agents

44 Coating Systems & Additives
39 Fillers, Diluents & Binders
19 Direct Compression
19 Controlled & Modified Release
18 Disintegrants & Superdisintegrants
13 Taste Masking
13 Chewable & Orodispersible Aids
12 Granulation
12 Thickeners and Stabilizers
10 Co-Processed Excipients
9 Lubricants & Glidants
8 Film Formers & Plasticizers
5 Parenteral
5 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules
4 API Stability Enhancers
4 Rheology Modifiers
2 Solubilizers
2 Emulsifying Agents
2 Topical
1 Surfactant & Foaming Agents

DIGITAL CONTENT

19 NEWS #PharmaBuzz

19 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 9 Finished Drug Prices, 14 Annual Reports

1 US Medicaid Prescriptions
9 Finished Drug Prices
14 Annual Reports

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

8 US Patents, 6 Health Canada Patents

8 US Patents
6 Health Canada Patents

$ API Ref.Price (USD/KG) : 48,251 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

8 All

01 8VALINOR

filter Patent Number Reset all filters

8 All

01 27056500

02 27786133

03 28067431

04 29012469

filter API Patent Reset all filters

8 All

01 4Y

02 4Blank

filter FDF Patent Reset all filters

8 All

01 6Y

02 2Blank

filter Expiration Date Reset all filters

8 All

01 22024-06-29

02 22024-12-16

03 22028-09-16

04 22032-04-02

Product Main Page

01

VALINOR

NALOXEGOL OXALATE

The Generic Rx Session

Not Confirmed

VALINOR

Country

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-12-16

NALOXEGOL OXALATE

US Patent Number : 8067431

Drug Substance Claim :

Drug Product Claim :

Application Number : 204760

Patent Use Code : U-1185

Delist Requested :

Patent Use Description : TREATMENT OF OPIOID-IN...

Patent Expiration Date : 2024-12-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

VALINOR

NALOXEGOL OXALATE

The Generic Rx Session

Not Confirmed

VALINOR

Country

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-12-16

NALOXEGOL OXALATE

US Patent Number : 8067431

Drug Substance Claim :

Drug Product Claim :

Application Number : 204760

Patent Use Code : U-1185

Delist Requested :

Patent Use Description : TREATMENT OF OPIOID-IN...

Patent Expiration Date : 2024-12-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

VALINOR

NALOXEGOL OXALATE

The Generic Rx Session

Not Confirmed

VALINOR

Country

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-06-29

NALOXEGOL OXALATE

US Patent Number : 7056500

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204760

Patent Use Code : U-1185

Delist Requested :

Patent Use Description : TREATMENT OF OPIOID-IN...

Patent Expiration Date : 2024-06-29

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

VALINOR

NALOXEGOL OXALATE

The Generic Rx Session

Not Confirmed

VALINOR

Country

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-06-29

NALOXEGOL OXALATE

US Patent Number : 7056500

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204760

Patent Use Code : U-1185

Delist Requested :

Patent Use Description : TREATMENT OF OPIOID-IN...

Patent Expiration Date : 2024-06-29

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

VALINOR

NALOXEGOL OXALATE

The Generic Rx Session

Not Confirmed

VALINOR

Country

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-09-16

NALOXEGOL OXALATE

US Patent Number : 7786133

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204760

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-09-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

VALINOR

NALOXEGOL OXALATE

The Generic Rx Session

Not Confirmed

VALINOR

Country

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-04-02

NALOXEGOL OXALATE

US Patent Number : 9012469

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204760

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-04-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

VALINOR

NALOXEGOL OXALATE

The Generic Rx Session

Not Confirmed

VALINOR

Country

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-04-02

NALOXEGOL OXALATE

US Patent Number : 9012469

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204760

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-04-02

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

VALINOR

NALOXEGOL OXALATE

The Generic Rx Session

Not Confirmed

VALINOR

Country

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-09-16

NALOXEGOL OXALATE

US Patent Number : 7786133

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204760

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-09-16

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!